©  2019 - McMaster University Update in Thromboembolism 


Privacy Policy |  McMaster CHSE Website

Download the McMaster CHSE Mobile APP


Shawn Locke, CHSE Coordinator
McMaster University, Continuing Health Sciences Education
1280 Main St. W., DBHSC, Room 5004, Hamilton, ON L8S 4K1
P: 905-525-9140 ext. 21098
F: 905-572-7099



P: 905-525-9140 ext. 22671

Please register on-site.

Please join us at the

6th Annual Canadian


September 28, 2019

Hamilton Convention Centre


Physicians, Nurses, Nurse Practitioners, Residents, Physician Assistants, Social Workers and other Allied Health Practitioners involved in the care of patients with sickle cell disease, thalassemia and associated iron overload.


 By attending this activity, participants will be able to: 

  • Describe new evidence in curative therapy for sickle cell disease and thalassemia. 

  • Discuss optimal approaches to diagnostic and genetic testing in hemoglobinopathies. 

  • Apply current evidence in prevention and treatment of stroke and thrombosis in hemoglobinopathies. 

  • Manage complex cases, including iron overload, non-transfusion dependent thalassemia and sickle cell disease. 



Download the brochure

Sign-up for email updates or email 


The 6th Annual Canadian Haemoglobinopathy Conference invites abstract submissions to be considered for

oral or poster presentation. Please click here for more information.




P: 905-525-9140 x 21098


Accreditation Statement


McMaster University, Continuing Health Sciences Education Program (CHSE) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide CFPC Mainpro+ and RCPSC Maintenance of Certification (MOC) study credits for Continuing Medical Education.

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and approved by McMaster University, Continuing Health Sciences Education Program for up to 5.5 MOC Section 1 hours.

Through an agreement between The Royal College of Physicians and Surgeons of Canada and The American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 CreditsTM. Information on the process to convert Royal College MOC credit to AMA credit can be found at:

*Each healthcare provider should claim only those hours of credit that he/she actually spent in the educational activity.



Hamilton Convention Centre by Carmen's

1 Summers Lane, Hamilton, Ontario, Canada L8P 4Y2


Sheraton Hamilton Hotel

116 King Street West, Hamilton, Ontario, Canada L8P 4V3


Reservations be made by contacting 24 hours, toll-free reservations line at

1-888-627-8161 and asking for “McMaster Thrombo Room Block”.


Speaker Bios

6th Annual Canadian Haemoglobinopathy Conference

Williams Suzan.jpg

Dr. Suzan Williams completed a BSc at McMaster University, Hamilton, Ontario in 1993.  She completed medical school at the University of Toronto in 1997. She completed pediatric and pediatric haematology oncology training at McMaster University Medical Centre in Hamilton, Ontario in 2003. She joined the full-time faculty in the Paediatric Hemostasis Program of the Hematology section in the  Division of Hematology / Oncology at the Hospital for Sick Children, in 2003. Currently a  clinician specialist in the of the Department of Paediatrics and an Associate  Professor at the University of Toronto.  She completed an MSc in Health Research Methodology at McMaster University in Hamilton, Ontario in 2006, and an MSc in Haemoglobinopathy through the University College London, London, United Kingdom in 2011.  Her clinical and research  interests are in the areas of thrombotic disorders and sickle cell disease and stroke.

University of Toronto

Toronto, ON

Dr. Suzan Williams

Ameil Joseph.png

Ameil Joseph is an Associate Professor in the School of Social Work at McMaster University.  He draws on perspectives of critical forensic mental health, mad studies, postcolonial theory, critical race theory, and critical disability studies to analyze the historical production of ideas about difference, normalcy, sexuality, eugenics, race, ability and mental “illness” as they cohere, diverge, interdepend and perform within policy, law and practice. Ameil has presented and advocated across Canada, in the US and in Europe on issues related to racism, critical mental health and social justice. Ameil has over a decade of experience working in mental health, criminal justice and immigration services. Ameil is also the author of: Deportation and the confluence of violence within forensic mental health and immigration systems published by Palgrave-MacMillan. A historiographical post-colonial analysis of the practice of deportation in Canada for those identified as “undesirable”.

McMaster University

Hamilton, Ontario

Dr. Ameil Joseph

Rakhi Naik.png

Dr. Rakhi Naik is the Associate Director for Hematology for the Hematology/Oncology Fellowship Program and is an Assistant Professor of Medicine at Johns Hopkins University. She received her undergraduate degree in Biomedical & Electrical Engineering from Duke University and her M.D. with Honors in Research from Cornell University. She then completed her Internal Medicine Residency and Hematology Fellowship training at Johns Hopkins, where she also served as Assistant Chief of Service (Chief Resident). Dr. Naik has additionally received a Masters in Health Science (MHS) from the Graduate Training Program in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health.

Dr. Naik's research, educational, and clinical interests are focused on non-malignant hematologic disorders.  Her primary research expertise is in sickle cell trait and sickle cell disease.  Specifically, her research focuses on chronic kidney disease in sickle cell trait and venous thromboembolism in sickle cell disease.

Dr. Naik is an active member of the American Society of Hematology (ASH) Committee on Training and serves on the ASH Recruitment and Retention Workforce, which aims to increase trainee recruitment into non-malignant hematology. In her role as Associate Program Director for Hematology, she runs one of the only single-board hematology fellowship programs in the United States.

Dr. Naik specializes in the treatment of adult patients with wide-array of blood and bone marrow disorders. Her primary focus is caring for patients with coagulation disorders such as abnormal bleeding and clotting, immune cytopenias such as ITP, AIHA, and TTP, hemoglobinopathies, myeloproliferative neoplasms and myeloid disorders.

Johns Hopkins University,

Baltimore, Maryland, USA

Dr. Rakhi Naik

John Waye.png

John Waye is Director of Laboratory Genetics at Hamilton Health Sciences, as well as Professor in the Department of Pathology and Molecular Medicine at McMaster University. He received a BSc from the University of Guelph (1981), MSc from McMaster University (1984), and PhD from the University of Toronto (1987). John is a Diplomate of the American Board of Medical Genetics and Genomics (Clinical Molecular Genetics), and Fellow of the American College of Medical Genetics. Since joining Hamilton Health Sciences in 1990, the primary focus of his work has been laboratory testing for thalassemia, sickle cell disease and other hemoglobinopathies. This includes carrier testing, prenatal diagnosis, diagnosis of affected individuals, and confirmation of newborn screening results. The laboratory serves as a reference laboratory for the Province of Ontario, annually handling several thousand patient samples. John regularly presents at scientific meetings and has published numerous articles dealing with hemoglobinopathies.  

McMaster University

Hamilton, Ontario

Dr. John Waye

Courtny Fitzhugh.png

Courtney Fitzhugh received her B.S. magna cum laude from the University of California, Los Angeles in 1996, and her M.D. from the University of California, San Francisco in 2001. During medical school, Dr. Fitzhugh participated in the NIH Clinical Research Training Program, where she studied with Dr. John Tisdale at the NHLBI. After receiving her M.D., Dr. Fitzhugh completed a joint residency in internal medicine and pediatrics at Duke University Medical Center, and in 2005 she did a combined adult hematology and pediatric hematology-oncology fellowship at the NIH and Johns Hopkins Hospital. Dr. Fitzhugh returned to the NHLBI in 2007 and was appointed as Assistant Clinical Investigator in 2012 and Clinical Tenure Track Investigator in 2016. She is a member of the American Society of Hematology.

NIH/NHLBI, Bethesda,

Maryland, USA

Dr. Courtney Fitzhugh



07:45 – 08:20    

Registration and Breakfast


08:20 – 08:30    

Welcome and Introductions


08:30 – 09:00     

Stroke and Cerebrovascular Disease in Sickle Cell Disease: Prevention and Treatment 

Dr. Suzan Williams, University of Toronto, Toronto, Ontario


09:00 – 09:30         

Navigating Racial Issues in Canadian Healthcare

Dr. Ameil Joseph, McMaster University, Hamilton, Ontario


09:30 – 10:00    

Thrombosis in Sickle Cell Disease and Thalassemia 

Dr. Rakhi Naik, Johns Hopkins University, Baltimore, Maryland, USA


10:00 – 10:20

Panel Discussion and Questions


10:20 – 10:45

Morning Break 


10:45 – 11:15

Genetic Testing in Hemoglobinopathies – Current State of the Art

Dr. John Waye, McMaster University, Hamilton, Ontario


11:15 – 11:45

Update on Curative Therapies for SCD and Thalassemia 

Dr. Courtney Fitzhugh, NIH/NHLBI, Bethesda, Maryland, USA


11:45 – 12:00

Panel Discussion and Questions


12:00 – 13:00



13:00 – 14:00

Oral Abstracts


14:10 – 14:55

Breakout Sessions 1


A. Creating and Identifying Effective Patient Education Resources 

Catherine Corriveau-Bourke – University of Alberta

Surabhi Rawal – McGill University


B. Challenging Cases in Iron Overload 

Jacob Pendergrast – University of Toronto

John Wu – University of British Columbia


C. Challenging Cases in Sickle Cell Disease 

Ewurabena Simpson – University of Ottawa

Andrew Binding – William Osler Health System - Brampton Civic Hospital        


15:00 – 15:45

Breakout Sessions 2 


A. Strategies to Optimize Hydroxyurea Acceptance and Adherence 

Karen Charpentier – SickKids Hospital

Colleen Johnson – Toronto General Hospital


        B. Challenging Cases in Non-Transfusion Dependent Thalassemia 

Kevin Kuo – University of Toronto

Rob Klaassen – University of Ottawa


        C. Caring for the Hemoglobinopathy Healthcare Provider - Compassion Fatigue and Burnout 

Michelle Cassidy – Hamilton Health Sciences

Linda Waterhouse – Hamilton Health Sciences


15:45 – 16:00

Coffee Break


16:00 – 17:00

CanHaem AGM